Abstract 329: Potential Role of Enrichment Strategies with CAC Testing for Future Clinical Trials Assessing PCSK-9 Inhibitors Efficacy Among Diabetics Without Established Cardiovascular Disease

Publication Date

2015

Presented At:

American Heart Association Quality of Care and Outcomes Research (QUA Outcome 2015 Sessions)

Content Type

Presentation

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS